Skip to main content
. 2014 Feb 10;348:g1285. doi: 10.1136/bmj.g1285

Table 4.

Prespecified labour and birth outcomes in women with BMI ≥25 at trial entry by treatment group. Values are numbers (%) of women and treatment effects are relative risks based on imputed data unless otherwise indicated

Outcome Lifestyle advice (n=1075*) Standard care (n=1067*) Treatment effect (95% CI), P value
Preterm birth 62 (6) 83 (8) 0.75 (0.54 to 1.03), 0.07 0.74 (0.54 to 1.02), 0.07
Chorioamnionitis requiring antibiotics 27 (3) 33 (3) 0.81 (0.49 to 1.34), 0.41 0.78 (0.48 to 1.29), 0.34
Induction of labour 390 (36) 378 (35) 1.02 (0.91 to 1.15), 0.68 1.03 (0.92 to 1.15), 0.63
Antibiotics during labour 439 (41) 454 (43) 0.96 (0.87 to 1.06), 0.43 0.97 (0.88 to 1.07), 0.57
Caesarean section 370 (34) 389 (37) 0.94 (0.84 to 1.06), 0.33 0.95 (0.85 to 1.06), 0.34
Postpartum haemorrhage >600 mL 168 (18) 177 (17) 0.94 (0.77 to 1.14), 0.53 0.94 (0.77 to 1.14), 0.50
3rd/4th degree perineal trauma 28 (3) 20 (2) 1.37 (0.78 to 2.43), 0.28 1.36 (0.77 to 2.40), 0.29
Wound infection 32 (3) 30 (3) 1.05 (0.65 to 1.72), 0.83 1.04 (0.64 to 1.70), 0.87
Endometritis 12 (1) 10 (1) 1.18 (0.51 to 2.72), 0.70 1.18 (0.51 to 2.72), 0.69
Postpartum antibiotics 99 (9) 98 (9) 1.00 (0.76 to 1.31), 1.00 0.98 (0.75 to 1.28), 0.90
Mean (SD) postnatal length of stay (mother) (days)‡ 2.85 (1.79) 2.91 (1.71) 0.98 (0.93 to 1.03), 0.37 0.97 (0.93 to 1.02), 0.31
Thromboembolic disease 1 (0.1) 2 (0.2) NA, 0.62§ NA

NA=not applicable.

*Includes all liveborn infants.

†Adjusted analyses included stratification variables BMI category, parity, and centre.

‡Treatment effects are ratios of means based on imputed data.

§P value derived Fisher’s exact test.